Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension

NCT03001414 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class

Stopped Lower than anticipated enrollment

Conditions

Interventions

Sponsor

Northern Therapeutics

Collaborators